MYCN and neuroblastoma: However, to study neuroblastoma disease in vivo, several mouse models have been developed through genetic engineering [9,10], the TH-MYCN transgenic mouse model (which expresses human MYCN specifically in neuroblasts under the control of the tyrosine hydroxylase (TH) promoter) being the most widely used.